TPT Global Tech (OTCMKTS:TPTW) is based out of San Diego, California, and is involved in a wide range of businesses. TPT Global Tech is primarily a tech company but it also involved in a range of industries like medical technology, technology solutions, and international and domestic syndication of content as well. 


Earlier this month on March 18, the company announced that it started a new branch named TPT MedTech UK. The entity has been launched with the view of making a range of products from TPT Global Tech easily available in the United Kingdom. 

Some of the products include Mobile QuickLAB, secure QuickPASS range of products, and SaniQUIK. The company will not only distribute these products in the United Kingdom but also in the EMEA region (Europe, Middle East, and Africa). 

The products mentioned are meant for quick COVID 19 testing and also for other forms of medical testing. It is a significant development for the company since TPT MedTech UK could help the company take its products to a vast new market. 

ECGI Holdings Closed January with a Strong Strategic Move to Conquer the Cannabis Market in California

The company has been at the forefront of innovation for quite some time. In the initial stages of the coronavirus pandemic, it realized that the challenge would require solutions that combined technology and medicine. 

TPT Global Tech moved into the medical sector fairly quickly and established its medical division in order to meet the challenge. The company’s experience in bringing new products into the market helped it in coming up with effective medical technology products to tackle COVID 19. 

The products hit the market pretty quickly and soon enough, these products were launched across the United States and abroad. Stephen J. Thomas, the Chief Executive Officer to TPT Global Tech, stated that as the countries in the EAMA and the United Kingdom relax restrictions, it could be the right time for the company to launch its products in those regions. He went on to state that the initial response to the products have been encouraging.

Neither PSN nor its owners, members, officers, directors, partners, consultants, nor anyone involved in the publication of this website, is a registered investment adviser or broker-dealer or associated person with a registered investment adviser or broker-dealer and none of the foregoing make any recommendation that the purchase or sale of securities of any company profiled in the PSN website is suitable or advisable for any person or that an investment or transaction in such securities will be profitable. The information contained in the PSN website is not intended to be, and shall not constitute, an offer to sell nor the solicitation of any offer to buy any security. The information presented in the PSN website is provided for informational purposes only and is not to be treated as advice or a recommendation to make any specific investment. Please consult with an independent investment adviser and qualified investment professional before making an investment decision.